A Falahati

Mild Renal Impairment and the Efficacy and Safety of Liraglutide

Jaime A. Davidson, Jason Brett, A Falahati et al. · Endocrine Practice · 2010 · 79 citations

Pharmacy, Nephrology, Pharmacotherapy +12

Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and <65 Years of Age: A Pooled Analysis from Phase III Studies

Bruce W. Bode, Jason Brett, A Falahati et al. · ˜The œAmerican journal of geriatric pharmacotherapy · 2011 · 62 citations

Medicine, Endocrinology, Pharmacology +11

Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time

Baptist Gallwitz, Allan Vaag, A Falahati et al. · International Journal of Clinical Practice · 2009 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +16

Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model

Anders Toft, A Falahati, Adam Steensberg · European Journal of Applied Physiology · 2010 · 45 citations

Life Sciences, Immunology, Physiology +12

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis

Jorge Plutzky, A. J. Garber, A Falahati et al. · Canadian Journal of Diabetes · 2009 · 32 citations

Medicine, Endocrinology, Pharmacology +12